Employer health plans brace for ongoing soaring costs as weight-loss drug utilization rises. What trends are coming down the ...

Supervised lifestyle intervention from a medical professional may help maximize fat loss and minimize muscle tissue loss in ...

Glucagon-like peptide 1 (GLP-1) receptor agonists are transforming the treatment landscape for type 2 diabetes ( T2D) and obesity, in addition to their cardiovascular benefits. These drugs also ...

People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper supervision, and a protein-rich diet, the results of a new study suggest.

Beccarelli was prescribed the anti-obesity ... a GLP-1 drug. There’s no high-level study to provide an answer, so Dayan always asks his patients to get clearance from their oncology team before ...

At least 14 states already cover the cost of GLP-1 medications for obesity treatment for patients ... about ordering a cost-benefit analysis before making the commitment. Already, West Virginia ...

The research, carried out by obesity experts in New York, adds to the growing evidence that these medications can help people manage obesity effectively. GLP-1 is a type of incretin, a gut hormone ...